Adaptimmune announces opening of Phase I/IIa clinical trial in ovarian cancer
7/29/2013
Adaptimmune has announced that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif...
Adaptimmune announces opening of Phase I/IIa clinical trial in ovarian cancer
7/29/2013
Adaptimmune has announced that it has opened a Phase I/IIa, multiple-site, two-cohort, open-label clinical trial in ovarian cancer at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif...
Doctors pioneer use of 'bug' device to protect critically ill patients
7/29/2013
Doctors in Southampton are the first in the world to fit critically ill patients with a revolutionary bug-like device to detect dangerous blood sugar levels...
Significant advances have taken place in the management of patients with advanced and metastatic non-small-cell lung cancer (NSCLC) over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner. More recently, the importance of pathologic subtype has been recognized...
How obesity impacts advanced non-small cell lung cancer
7/29/2013
Obesity increases health risks for many things. Researchers wanted to know the impact of obesity on outcomes of patients with advanced non-small cell lung cancer...
Scientists have discovered a new molecule that prevents cancer cells from responding and surviving when starved of oxygen and which could be developed into new treatments for the disease, according to new research published in the Journal of the American Chemical Society...
From gold, a new way to control blood clotting
7/29/2013
Using gold nanoparticles, MIT researchers have devised a new way to turn blood clotting on and off. The particles, which are controlled by infrared laser light, could help doctors control blood clotting in patients undergoing surgery, or promote wound healing. Currently, the only way doctors can manage blood clotting is by administering blood thinners such as heparin...
PTEN discovery provides knowledge to individualize cancer treatment
7/29/2013
Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics...
Higher Cancer Incidences Found in Regions Near Refineries and Plants that Release Benzene
7/29/2013
The incidence of a particular type of blood cancer is significantly higher in regions near facilities that release the chemical benzene into the environment. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society...
The taller the woman, the higher her cancer risk
7/28/2013
The ability to reach items on high shelves and easily see through a crowd may no longer have the same appeal for some women. A study recently published in Cancer Epidemiology, Biomarkers & Prevention finds a link between postmenopausal women's height and cancers...